Muhlenkamp & Co’s CVS Health CVS Stock Holding History

Muhlenkamp & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,000	Closed	-$236K	–	81
2017 Q1	$236K	Buy	+3,000	New	+$240K	0.07%	73

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Muhlenkamp & Co's CVS Position: Q3 2023 in Review

Muhlenkamp & Co sold out of CVS Health (CVS) in Q3 2023, closing a stake of 110,695 shares — an estimated $7.65M sold.

Muhlenkamp & Co first reported a position in CVS in Q3 2019 and held it in 14 quarters. The position peaked at $11.2M in Q4 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Muhlenkamp & Co reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
Muhlenkamp & Co sold 110,695 CVS Health shares in Q3 2023, an estimated $7.65M.
Muhlenkamp & Co first reported a position in CVS Health in Q3 2019 and held it in 14 quarters.
Muhlenkamp & Co's CVS Health position peaked at $11.2M in Q4 2021.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Muhlenkamp & Co's 13F filing for Q3 2023, filed 6 Dec 2023.